赴美上市｜纳斯达克｜上市新规｜上市审核｜专业赴美上市服务机构 2025年12月19日起生效的自由裁量权规则 IM-5101-3新规中，明确赋予交易所裁量权：即便企业完全满足净利润、市值等常规上市指标，仍可能因潜在风险 被拒绝IPO申请，其中"中介机构关联风险"被列为核心审查之一，成为拟上市企业不可忽视的合规重点。 ————这意味着，赴美上市已从企业自身实力要求，延伸至中介机构的合规能力与专业底蕴较量，选对合作伙伴，成为能否成功登陆美股的关键。 此次纳斯达克新规对中介机构的监管要求升级，精准打击各类隐性风险。在过往的上市审核中，中介机构仅为辅助角色，而新规将其推向风险防控的核心， 明确以下情形将直接影响企业上市进程。 （纳斯达克新规） 主要是中介机构关联风险：若公司承销商、审计师、律师事务所、经纪人、清算公司或其他专业服务合作方，其监管历史、负责人背景及过往交易模式（如 引发股价剧烈波动的操作）存在问题，即便拟上市企业自身无过错，也可能因中介的不良记录被否决申请。若中介公司为新实体，其负责人曾涉监管问题的 历史将被追溯。 这种审查逻辑，本质上是要求中介机构具备与美股监管体系相匹配的专业能力，而非仅满足表面合规条 ...

Core Viewpoint - The regulatory framework of the US and China capital markets is continuously adjusting, creating both opportunities and challenges for Chinese companies seeking cross-border financing. The increasing entry barriers for traditional IPOs and the evolving SPAC landscape are pushing smaller enterprises towards the OTC market as a pragmatic entry point into international capital markets [1]. Group 1: Direct IPO (NYSE/NASDAQ) - The traditional IPO route offers significant advantages such as large fundraising potential (with a proposed minimum of $25 million), strong liquidity, and notable brand endorsement, making it suitable for mature tech or manufacturing firms [2]. - However, the disadvantages are considerable, including a lengthy SEC review process of 12-24 months, underwriting fees of 7%-10% of the raised amount, and stringent financial criteria, particularly with the anticipated increase in market capitalization requirements by NASDAQ [2]. - Post-2025, while the resumption of filing windows is expected, compliance issues related to VIE structures and data security reviews remain significant obstacles [2]. Group 2: SPAC Merger Listing - The SPAC model allows for rapid listing through a "shell company fundraising - merger injection" approach, reducing the timeline to 6-9 months and imposing no strict profitability requirements [3]. - Nonetheless, with tightening regulations expected in 2025, SPACs face challenges such as high redemption rates (averaging over 97%) and rising PIPE financing costs (5%-7% of the raised amount), making it more suitable for companies in AI and renewable energy sectors that can effectively communicate their value [3]. Group 3: OTC Market Listing - The OTC market represents the lowest entry barrier, characterized by its "stepping stone" attribute, making it an optimal choice for small and medium-sized enterprises [4]. - For example, the OTCQB listing process typically spans 6-9 months, involving foundational setup (2-3 weeks), issuance and listing (3-6 weeks), requiring 50-100 shareholders and a minimum share price of $1 [5]. - Companies can transition to NASDAQ by meeting specific criteria, such as net assets of at least $5 million or a two-year cumulative net profit of $750,000 alongside net assets of $4 million, with additional requirements including 1 million shares in circulation and a share price of at least $4 [6]. Group 4: Compliance Preparation - The compliance preparation phase for OTC listing takes approximately 4-5 weeks, involving DTC custody applications and drafting the S-1 prospectus [7]. - Following this, the SEC review process lasts about 4 weeks, during which the application is submitted, inquiries are addressed, and a stock code is obtained [7].

Core Viewpoint - The article discusses a strategic approach for companies considering listing in the U.S. capital markets, emphasizing a "step-up" listing strategy that begins with the OTC market, allowing for a more cost-effective and efficient path to higher capital market stages [2]. Group 1: Listing Strategy - The "step-up" listing strategy is not merely a shell acquisition but a strategic entry into the OTC market, facilitating gradual advancement to higher capital market platforms [2]. - Companies can significantly reduce compliance risks and historical disputes by utilizing clean and compliant shell companies, which have no litigation or debt [5]. - The flexible equity structure of preferred and common stocks meets the needs for large-scale financing and provides tools for future capital operations such as mergers and refinancing [6]. Group 2: Cost and Services - The cost of acquiring a shell company is under $300,000, allowing businesses to inject assets without operational concerns, thus streamlining the integration process [7]. - Huayi Capital offers comprehensive services, including shell selection, acquisition of controlling interests, information changes, stock trading, asset injection, OTC level upgrades, and subsequent market value management [7]. Group 3: OTC Market Transition - Huayi Capital provides tailored services for companies planning to transition from OTC to higher market levels, assisting with compliance, financial metrics, and SEC communications [8][12]. - A recent case involved a successful upgrade of an agricultural company from the OTC expert market to the PINK market and then to the OTC ID market, enhancing its compliance and capital foundation for future NASDAQ listing [9]. Group 4: Market Examples - Acorn International Energy Company successfully transitioned from the OTC market to NASDAQ, raising approximately $7.8 million at a 35% valuation increase compared to its OTC period [13]. - The article highlights the advantages of OTC transitions, such as lower thresholds, stable valuations, and flexible timing for companies not yet meeting traditional IPO requirements [12]. Group 5: Company Support - Huayi Capital aims to provide rapid and seamless support for companies seeking to optimize their valuations for significant capital decisions, leveraging its extensive industry experience [14]. - The SHELL WORLD platform by Huayi Capital focuses on offering high-quality shell resources and comprehensive services to facilitate efficient connections with international capital markets [14].